Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Am J Chin Med ; 45(8): 1761-1772, 2017.
Article in English | MEDLINE | ID: mdl-29121803

ABSTRACT

Carnosol is an anti-oxidant and anti-inflammatory compound from rosemary. In this paper, we investigated antitumor activity of carnosol against human osteosarcoma cells. We found the viability of human osteosarcoma MG-63 cells was significantly decreased in the presence of carnosol (cell viabilities: 17.2% for 20[Formula: see text]µg/ml of CS vs. 100% for control, [Formula: see text]). Carnosol induced apoptosis and cell cycle arrest in a dose-dependent manner in MG-63 cells. Furthermore, carnosol exposure increased the levels of reactive oxygen species (ROS). The pre-treatment of NAC, the ROS scavenger, blocked the inhibition of cell viability in the carnosol treatment, indicating that ROS is important in the antiproliferation effect. Moreover, we demonstrated that carnosol significantly induced autophagy and co-administration of autophagy inhibitor reduced the antiproliferating effect of carnosol. This result exhibited the cytotoxic effect of autophagy induced by carnosol in MG-63 cells. Interestingly, the treatment of NAC decreased carnosol-induced autophagy. Collectively, these data indicate that carnosol suppresses the viability of human osteosarcoma MG-63 cells by upregulation of apoptosis and autophagy, which are both mediated by ROS. Thus, carnosol might serve as a potential therapeutic agent against osteosarcoma.


Subject(s)
Abietanes/pharmacology , Antineoplastic Agents, Phytogenic , Apoptosis/drug effects , Autophagy/drug effects , Cell Survival/drug effects , Osteosarcoma/pathology , Reactive Oxygen Species/metabolism , Reactive Oxygen Species/pharmacology , Abietanes/isolation & purification , Anti-Inflammatory Agents , Antioxidants , Dose-Response Relationship, Drug , Humans , Rosmarinus/chemistry , Tumor Cells, Cultured
2.
J Agric Food Chem ; 65(13): 2670-2676, 2017 Apr 05.
Article in English | MEDLINE | ID: mdl-28301149

ABSTRACT

Methyl protodioscin (MPD), a furostanol saponin derived from the rhizomes of Dioscorea collettii var. hypoglauca (Dioscoreaceae), has been shown to exhibit broad bioactivities such as anti-inflammation and antitumor activities. Here, we explored the molecular mechanisms by which MPD induced apoptosis in MG-63 cells. The data showed that MPD significantly suppressed cell growth (cell viabilities: 22.5 ± 1.9% for 8 µM MPD versus 100 ± 1.4% for control, P < 0.01) and enhanced cell apoptosis. The exposure to MPD resulted in a significant induction of reactive oxygen species, loss of mitochondrial membrane potential, and activation of caspase-9 and caspase-3 (P < 0.01, all cases). Furthermore, treatment with MPD increased the levels of phosphorylated JNK and p38 MAPK and markedly decreased the levels of phosphorylated ERK in MG-63 cells. Co-administration of the JNK-specific antagonist, the p38-specific antagonist, or the caspase antagonist (P < 0.05, all cases) has reversed the apoptotic effects in MPD treatment. We also found that exposure to MPD resulted in a significant reduction in the protein level of anti-apoptotic proteins Bcl-2, survivin, and XIAP (P < 0.05, all cases). In conclusion, our results indicate that MPD induces apoptosis of human osteosarcoma MG-63 cells, at least in part, by caspase-dependent and MAPK signaling pathways.


Subject(s)
Apoptosis/drug effects , Bone Neoplasms/enzymology , Caspase 3/metabolism , Caspase 9/metabolism , Dioscorea/chemistry , Diosgenin/analogs & derivatives , Osteosarcoma/enzymology , Plant Extracts/pharmacology , Saponins/pharmacology , Bone Neoplasms/drug therapy , Bone Neoplasms/genetics , Bone Neoplasms/physiopathology , Caspase 3/genetics , Caspase 9/genetics , Cell Line, Tumor , Diosgenin/pharmacology , Humans , JNK Mitogen-Activated Protein Kinases/genetics , JNK Mitogen-Activated Protein Kinases/metabolism , MAP Kinase Signaling System/drug effects , Membrane Potential, Mitochondrial/drug effects , Osteosarcoma/drug therapy , Osteosarcoma/genetics , Osteosarcoma/physiopathology , Phosphorylation , bcl-2-Associated X Protein/genetics , bcl-2-Associated X Protein/metabolism
3.
J Agric Food Chem ; 64(21): 4220-6, 2016 Jun 01.
Article in English | MEDLINE | ID: mdl-27171502

ABSTRACT

Ursolic acid (UA), a naturally occurring pentacyclic triterpene acid found in many medicinal herbs and edible plants, has been shown to trigger apoptosis in several lines of tumor cells in vitro. We found that treatment with UA suppressed the viability of human osteosarcoma MG-63 cells and induced cell cycle arrest at sub-G1 and G2/M phases. Furthermore, exposure to UA induced intracellular oxidative stress and collapse of mitochondrial membrane permeability, resulting in the subsequent activation of apoptotic caspases 8, 9, and 3 as well as PARP cleavage, and ultimately apoptosis in MG-63 cells. Moreover, protein analysis of mitogen-activated protein kinase (MAPK)-related protein expression showed an increase in activated ERK1/2, JNK, and p38 MAPK in UA-treated MG-63 cells. In addition, UA-induced apoptosis was significantly abolished in MG-63 cells that had been pretreated with inhibitors of caspase 3, 8, and 9 and ERK1/2. Furthermore, UA-treated MG-63 cells also exhibited an enhancement in Bax/Bcl-2 ratio, whereas anti-apoptotic XIAP and survivin were down-regulated. Taken together, we provide evidence demonstrating that UA mediates caspase-dependent and ERK1/2 MAPK-associated apoptosis in osteosarcoma MG-63 cells.


Subject(s)
Apoptosis/drug effects , Bone Neoplasms/physiopathology , Caspase 3/metabolism , Caspase 8/metabolism , Caspase 9/metabolism , Osteosarcoma/physiopathology , Triterpenes/pharmacology , Bone Neoplasms/enzymology , Bone Neoplasms/genetics , Bone Neoplasms/metabolism , Caspase 3/genetics , Caspase 8/genetics , Caspase 9/genetics , Cell Line, Tumor , Humans , MAP Kinase Signaling System/drug effects , Mitogen-Activated Protein Kinases/genetics , Mitogen-Activated Protein Kinases/metabolism , Osteosarcoma/enzymology , Osteosarcoma/genetics , Osteosarcoma/metabolism , Ursolic Acid
4.
J Arthroplasty ; 28(6): 954-9, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23602417

ABSTRACT

This prospective, randomized, and controlled study was conducted to assess Traditional Chinese Medicine (TCM) for pain control, alone and in conjunction with a standard inpatient rehabilitation program, during the five days immediately following total knee arthroplasty (TKA). Forty-one patients undergoing primary unilateral TKA between February, 2010 and January, 2011 were randomly assigned to one of three groups. Levels of pain were then monitored using a Visual Analogue Scale (VAS). Significant alleviation of pain and diminution of flexion contractures were achieved using TCM, with and without standard rehabilitation. These outcomes support use of TCM immediately post-TKA to facilitate patient recovery.


Subject(s)
Arthroplasty, Replacement, Knee/rehabilitation , Manipulation, Orthopedic/methods , Medicine, Chinese Traditional , Aged , Aged, 80 and over , Early Medical Intervention , Female , Humans , Inpatients , Male , Middle Aged , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL